119 related articles for article (PubMed ID: 7984939)
21. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
Klein E
J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
[TBL] [Abstract][Full Text] [Related]
22. Psychopharmacologic treatment of anxiety disorders in adolescents and children.
Popper CW
J Clin Psychiatry; 1993 May; 54 Suppl():52-63. PubMed ID: 8099578
[TBL] [Abstract][Full Text] [Related]
23. Can buspirone induce rebound, dependence or abuse?
Lader M
Br J Psychiatry Suppl; 1991 Sep; (12):45-51. PubMed ID: 1840763
[TBL] [Abstract][Full Text] [Related]
24. [A new therapeutic approach: the behavioral prescription of anxiolytics].
Marboutin JP; Légeron P; Rivière B
Encephale; 1990; 16(3):189-96. PubMed ID: 1974843
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacology of anxiolytics and their therapeutic use].
Tada K
Ryoikibetsu Shokogun Shirizu; 2003; (38):608-11. PubMed ID: 12877061
[No Abstract] [Full Text] [Related]
26. Developments in treatment of anxiety disorders: psychotherapy, pharmacotherapy, and psychosurgery.
Balon R
Depress Anxiety; 2004; 19(2):63-76. PubMed ID: 15022141
[TBL] [Abstract][Full Text] [Related]
27. Approaches to developing new anxiolytics and antidepressants.
Dubovsky SL
J Clin Psychiatry; 1993 May; 54 Suppl():75-83. PubMed ID: 8099580
[TBL] [Abstract][Full Text] [Related]
28. [When and how to stop anxiolytic drugs].
Nuss P
Rev Prat; 1999 Sep; 49(14 Suppl):S36-41. PubMed ID: 10887616
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and management of generalized anxiety disorder.
Roerig JL
J Am Pharm Assoc (Wash); 1999; 39(6):811-21; quiz 877-9. PubMed ID: 10609447
[TBL] [Abstract][Full Text] [Related]
30. Generalized anxiety disorder.
Gliatto MF
Am Fam Physician; 2000 Oct; 62(7):1591-600, 1602. PubMed ID: 11037076
[TBL] [Abstract][Full Text] [Related]
31. Treating anxiety while minimizing abuse and dependence.
Sussman N
J Clin Psychiatry; 1993 May; 54 Suppl():44-51. PubMed ID: 8099577
[TBL] [Abstract][Full Text] [Related]
32. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link.
Stahl SM
J Clin Psychiatry; 1997; 58 Suppl 8():20-6. PubMed ID: 9236732
[TBL] [Abstract][Full Text] [Related]
33. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
Arató M
J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
[No Abstract] [Full Text] [Related]
34. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
Chouinard G
J Clin Psychiatry; 2004; 65 Suppl 5():7-12. PubMed ID: 15078112
[TBL] [Abstract][Full Text] [Related]
35. [Anxiety and the mechanisms of action of anxiolytics].
Marino A; Costa R
Recenti Prog Med; 1993 Feb; 84(2):129-41. PubMed ID: 8096650
[TBL] [Abstract][Full Text] [Related]
36. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
[TBL] [Abstract][Full Text] [Related]
37. Abecarnil, a new beta-carboline, in the treatment of anxiety disorders.
Aufdembrinke B
Br J Psychiatry Suppl; 1998; (34):55-63. PubMed ID: 9829018
[TBL] [Abstract][Full Text] [Related]
38. [Effects of antidepressants on cognitive functions. Review of the literature].
Amado-Boccara I; Gougoulis N; Poirier-Littré MF; Galinowski A; Lôo H
Encephale; 1994; 20(1):65-77. PubMed ID: 8174512
[TBL] [Abstract][Full Text] [Related]
39. New molecular targets for antianxiety interventions.
Gorman JM
J Clin Psychiatry; 2003; 64 Suppl 3():28-35. PubMed ID: 12662131
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacotherapy of panic disorder].
Bougerol T; Farisse J
Encephale; 1996 Dec; 22 Spec No 5():46-53. PubMed ID: 9138947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
